CMC Enterprise Pharmacy, Charlotte, NC
Is CMC Enterprise Pharmacy registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility, with FDA’s note “Out of business”.
Does CMC Enterprise Pharmacy hold a North Carolina pharmacy license?
State board of pharmacy records for North Carolina are not checked: the board’s website refused automated requests with an access error, and this index does not work around blocks.
Has CMC Enterprise Pharmacy had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter (Jun 4, 2020) and 2 FMD-145 letters (2 on Jul 17, 2020) for CMC Enterprise Pharmacy. State board of pharmacy records for North Carolina are not checked: the board’s website refused automated requests with an access error, and this index does not work around blocks.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- CMC Enterprise Pharmacy
- Location
- Charlotte, NC
- Type as FDA labels it
- 503A
- FDA’s note
- Out of business
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 1
- Warning letters on FDA’s actions page
- 1
- Latest action on that page
- Jul 17, 2020
- FDA Data Dashboard inspections
- 1 inspection: 1 OAI; 1 published Form 483
- State board records
- Not checked
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as CMC Enterprise Pharmacy, a 503A facility, with 4 dated actions.
| Document | |||
|---|---|---|---|
| Jul 17, 2020 | FMD-145 letter | FMD-145 Letter Issued 07/17/2020 | Not linked by FDA |
| Jul 17, 2020 | FMD-145 letter | FMD-145 Letter Issued 07/17/2020 | FDA copy (archived) |
| Jun 4, 2020 | Warning letter | Warning Letter (06/04/2020) | FDA copy (archived) |
| Mar 22, 2019 | Form 483 | 483 Issued 03/22/2019 | fda.gov |
A Form 483 lists investigator observations, not a final FDA determination. A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists CMC Enterprise Pharmacy, Charlotte, NC (FEI number 3014539004), matched to this page by exact name, city and state. It lists 1 inspection: 1 OAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Mar 22, 2019 | Official Action Indicated (OAI) | Drug Quality Assurance (Drugs) | 3014539004 | 1083750 |
Form 483s FDA has published for this site
- Mar 22, 2019: Form 483 to CMC Enterprise Pharmacy, published Feb 19, 2025. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA links 1 Form 483 PDF for CMC Enterprise Pharmacy, but no observation text is shown, for the reasons below.
Linked 483s whose text is not shown
- Mar 22, 2019: FDA document 185494: its numbered observations could not be read reliably from the PDF text.
State board of pharmacy records
State board of pharmacy records for North Carolina are not checked: the board’s website refused automated requests with an access error, and this index does not work around blocks.
This page restates FDA’s lists. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
Records last pulled Nov 15, 2026. Every entry links to the original public record.